Prieto Miguel L, Youngstrom Eric A, Ozerdem Aysegul, Altinbas Kursat, Quiroz Danilo, Aydemir Omer, Yalin Nefize, Geske Jennifer R, Feeder Scott E, Angst Jules, Frye Mark A
Universidad de los Andes, Facultad de Medicina, Departamento de Psiquiatría, Santiago, Chile; Mayo Clinic Depression Center, Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
J Affect Disord. 2015 Feb 1;172:355-60. doi: 10.1016/j.jad.2014.09.047. Epub 2014 Oct 13.
There are no self-report scales that assess manic/hypomanic symptoms in patients with depression. The aim of this study was to explore the use of a modified screening instrument for bipolar disorder to assess current manic/hypomanic symptoms in patients with a depressive episode.
The study sample consisted of 188 patients with Structured Clinical Interview for DSM-IV-TR disorders (SCID) confirmed bipolar or major depressive disorder. We modified the Hypomania Checklist-32 (mHCL-32) to assess current instead of lifetime symptoms. An Exploratory Factor Analysis (EFA) was conducted to identify clusters of mHCL-32 items that were endorsed concurrently. A Latent Class Analysis (LCA) was carried out to identify groups of patients with similar mHCL-32 item endorsement patterns.
The EFA identified 3 factors: factor #1 ("elation-disinhibition-increased goal directed activity"), factor #2 ("risk-taking-impulsivity-substance use") and factor #3 (distractibility-irritability). The LCA yielded 3 classes (2 showing manic/hypomanic features). While class #1 patients endorsed more items related to disinhibition and racing thoughts, class #2 patients recognized more items associated with irritability and substance use.
Lack of an adequate gold standard measure of mixed depression to compare to, the cross-sectional design and the lack of a validation sample.
The mHCL-32 scale allowed a comprehensive and convergent delineation of hypomanic/manic symptoms in depression. Further validation of these findings is needed.
目前尚无用于评估抑郁症患者躁狂/轻躁狂症状的自评量表。本研究旨在探讨使用一种改良的双相情感障碍筛查工具来评估抑郁发作患者当前的躁狂/轻躁狂症状。
研究样本包括188例经《精神疾病诊断与统计手册第四版修订版》(DSM-IV-TR)障碍的结构化临床访谈(SCID)确诊为双相情感障碍或重度抑郁症的患者。我们对轻躁狂症状清单-32(mHCL-32)进行了修改,以评估当前症状而非终生症状。进行探索性因素分析(EFA)以识别同时被认可的mHCL-32项目集群。进行潜在类别分析(LCA)以识别具有相似mHCL-32项目认可模式的患者群体。
EFA确定了3个因素:因素1(“欣快-去抑制-目标导向活动增加”)、因素2(“冒险-冲动-物质使用”)和因素3(注意力分散-易激惹)。LCA产生了3个类别(2个显示躁狂/轻躁狂特征)。虽然第1类患者认可了更多与去抑制和思维奔逸相关的项目,但第2类患者识别出了更多与易激惹和物质使用相关的项目。
缺乏与之比较的足够的混合性抑郁症金标准测量方法、横断面设计以及缺乏验证样本。
mHCL-32量表能够全面且一致地描绘抑郁症中的轻躁狂/躁狂症状。需要对这些发现进行进一步验证。